Factor Bioscience to Deliver Six Digital Presentations at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting

On May 11, 2021 Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, reported its participation in the American Society of Gene & Cell Therapy (ASGCT) (Free ASGCT Whitepaper) 24th Annual Meeting to be held virtually May 11-14, 2021, at which Factor will deliver six digital presentations (Press release, Factor Bioscience, MAY 11, 2021, View Source;cell-therapy-asgct-24th-annual-meeting-301288301.html [SID1234579730]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"High-efficiency generation of biallelic gene knockout iPSC lines using mRNA gene editing." -to be presented by Mitchell Kopacz on May 11 from 8-10 am.
"Removing T0 constraint reveals differences in specificity of engineered gene-editing proteins." -to be presented by Mackenzie Parmenter on May 11 from 8-10 am.
"Knock-in iPS cell line generation using end-modified linear DNA donors." -to be presented by Aidan Simpson on May 11 from 8-10 am.
"Splint and ribozyme-free enzymatic synthesis and purification of long circular RNA for in vitro translation in human cells." -to be presented by Aisha Svihla on May 11 from 8-10 am.
"DNA-binding domains containing novel repeat sequences enable temperature-tunable gene editing in primary human cells." -to be presented by Yemi Osayame on May 11 from 8-10 am.
"Lipid-stripped albumin enables high-efficiency mRNA reprogramming of adult human fibroblasts." -to be presented by Jasmine Harris on May 11 from 8-10 am.
Factor reveals advances in mRNA, circleRNA, gene editing, cell reprogramming, and iPS cell-derived NK-cell technologies.

Digital presentations will be made available on the ASGCT (Free ASGCT Whitepaper) website on May 11, 2021. For more information on the upcoming American Society of Genetic & Cell Therapy (ASGCT) (Free ASGCT Whitepaper) Annual Meeting, visit View Source